Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Natural Products

• Publication date

  2009-03-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/np8005106PMID 19115838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides.

  2008cited by this paper
• Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy.

  2008cited by this paper
• Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology.

  2007cited by this paper
• Extracellular carbohydrate metabolites from Streptomyces coelicolor A3(2).

  2007cited by this paper
• Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

  2007cited by this paper
• Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.

  2007cited by this paper
• Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

  2007cited by this paper
• Isolation and structure of platencin: a FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activity.

  2007cited by this paper
• Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy.

  2006cited by this paper
• Platensimycin is a selective FabF inhibitor with potent antibiotic properties

  2006cited by this paper
• Discovery of FabH/FabF Inhibitors from Natural Products

  2006cited by this paper
• Empirical antibacterial drug discovery--foundation in natural products.

  2006cited by this paper
• Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

  2006cited by this paper
• The bacterial ribosome as a target for antibiotics

  2005cited by this paper
• Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors*

  2005cited by this paper
• Insights into the decoding mechanism from recent ribosome structures.

  2003cited by this paper
• Assembly of the 30S ribosomal subunit.

  2003cited by this paper
• Ribosome structure and the mechanism of translation.

  2002cited by this paper
• A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus

  2002cited by this paper
• Delaminomycins, novel nonpeptide extracellular matrix receptor antagonist and a new class of potent immunomodulator. I. Taxonomy, fermentation, isolation and biological activity.

  1993cited by this paper
• Delaminomycins, novel extracellular matrix receptor antagonist. III. Physico-chemical properties and structure elucidation of delaminomycins B and C.

  1993cited by this paper
• Delaminomycins, novel nonpeptide extracellular matrix receptor antagonist and a new class of potent immunomodulator. II. Physico-chemical properties and structure elucidation of delaminomycin A.

  1993cited by this paper
• Delaminomycins, novel extracellular matrix receptor antagonist. IV. Structure-activity relationships of delaminomycins and derivatives.

  1993cited by this paper
• The rpsD gene, encoding ribosomal protein S4, is autogenously regulated in Bacillus subtilis

  1991cited by this paper
• Relative avidity of etruscomycin to cholesterol and ergosterol

  1982cited by this paper
• 6"'-Deamino-6"'-hydroxy derivatives, as intermediates in the biosynthesis of neomycin and paromomycin.

  1981cited by this paper
• The structure of lucensomycin. II.

  1966cited by this paper
• The structure of lucensomycin. I.

  1966cited by this paper

• Enzymatic Stereoselective Nucleophilic Cyclization Governs Atypical Spirotetronate Assembly in Lucensimycin A Biosynthesis.

  2025cites this paper
• Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery

  2024cites this paper
• Extraction, Isolation, Characterization, and Bioactivity of Polypropionates and Related Polyketide Metabolites from the Caribbean Region

  2023cites this paper
• Potential of Streptomyces sp. strain AGS-58 in controlling anthracnose-causing Colletotrichum siamense from post-harvest mango fruits

  2022cites this paper
• N-Acetyl-Cysteinylated Streptophenazines from Streptomyces

  2021cites this paper
• The isolation of water-soluble natural products - challenges, strategies and perspectives.

  2021cites this paper
• Actinobacteria: Diversity, Plant Interactions and Biotechnology Applications

  2020cites this paper
• Plant Microbiomes for Sustainable Agriculture

  2020influential citation
• Altercrasins A–E, Decalin Derivatives, from a Sea-Urchin-Derived Alternaria sp.: Isolation and Structural Analysis Including Stereochemistry

  2019cites this paper
• Recent Developments in the Quest for Novel Microbial Natural Products

  2018cites this paper
• Biosynthesis and incorporation of an alkylproline-derivative (APD) precursor into complex natural products.

  2018cites this paper
• Actinomycetes: still a source of novel antibiotics.

  2017cites this paper
• Molecular Iodine-Mediated Difunctionalization of Alkenes with Nitriles and Thiols Leading to β-Acetamido Sulfides.

  2016cites this paper
• Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.

  2016cites this paper
• Strategies for target identification of antimicrobial natural products.

  2016cites this paper
• NaI-Mediated Acetamidosulphenylation of Alkenes with Nitriles as the Nucleophiles: A Direct Access to Acetamidosulfides.

  2015cites this paper
• A comprehensive review of glycosylated bacterial natural products.

  2015cites this paper
• Natural products as a source of drug leads to overcome drug resistance.

  2015cites this paper
• Altercrasin A, a Novel Decalin Derivative with Spirotetramic Acid, Produced by a Sea Urchin-Derived Alternaria sp.

  2015cites this paper
• Biodiversity in production of antibiotics and other bioactive compounds.

  2015cites this paper
• Discovering new bioactive molecules from microbial sources

  2014cites this paper
• Natural Products as Antimicrobial Agents – an Update

  2014cites this paper
• Antisense RNA Regulation and Application in the Development of Novel Antibiotics to Combat Multidrug Resistant Bacteria

  2013cites this paper
• Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening

  2013cites this paper
• Bioprospecting microbial metagenome for natural products

  2013cites this paper
• Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.

  2012cites this paper
• Natural Products in the 21st Century

  2012cites this paper
• Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.

  2011cites this paper
• Current approaches to exploit actinomycetes as a source of novel natural products

  2011cites this paper
• Systematics-guided bioprospecting for bioactive microbial natural products

  2011cites this paper
• Screening strategies for discovery of antibacterial natural products

  2011cites this paper
• Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling

  2010cites this paper
• Bioprospecting microbial natural product libraries from the marine environment for drug discovery

  2010cites this paper
• Discovery and antibacterial activity of glabramycin A–C from Neosartorya glabra by an antisense strategy

  2009cites this paper